Figure 4.
(A) When comparing ME/CFS patients to healthy control participants, no statistically significant differences in serum LBP level were found. (B) Only after immunological patient stratification was serum LBP level significantly elevated in patients without immunodeficiencies (ME/CFS − ID) compared to healthy control participants. (C) A similar effect was detected when comparing the LBP/sCD14 ratio of all ME/CFS patients to healthy control participants. (D) Again, only after immunological stratification did ME/CFS patients without immunodeficiencies show a significantly higher LBP/sCD14 ratio compared to the other test groups. LOD (LBP): 0.82 ng/mL; * p < 0.05.
